<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35908177</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-5111</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>The international journal of neuropsychopharmacology</Title><ISOAbbreviation>Int J Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>D2/D3 Receptor Agonism: Paving the Way for a New Therapeutic Target for Taste Disorders in Parkinson's Disease and Other Conditions?</ArticleTitle><Pagination><StartPage>933</StartPage><EndPage>935</EndPage><MedlinePgn>933-935</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ijnp/pyac042</ELocationID><Abstract><AbstractText>Chemosensory (i.e., olfaction and taste) dysfunction is common in neurodegenerative (e.g., Parkinson's disease, Alzheimer's disease, and dementia), psychiatric (e.g., depression, bipolar disorders, other conditions), and postinfectious (i.e., long COVID) diseases and in the elderly. Despite its impact on patients' quality of life, no established treatment for taste disorders exists so far. A recent report on the effect of pramipexole, a D2/D3 agonist, on taste performance in healthy participants provides support for a new potential therapeutic target for taste dysfunction to be tested in future randomized, placebo-controlled, clinical trials across several populations reporting gustatory symptoms.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of CINP.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3717-7697</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamburin</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1561-2187</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Neuropsychopharmacol</MedlineTA><NlmUniqueID>9815893</NlmUniqueID><ISSNLinking>1461-1457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>83619PEU5T</RegistryNumber><NameOfSubstance UI="D000077487">Pramipexole</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050637">Receptors, Dopamine D3</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Int J Neuropsychopharmacol. 2022 Sep 28;25(9):720-726. doi: 10.1093/ijnp/pyac030</RefSource><PMID Version="1">35605609</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077487" MajorTopicYN="N">Pramipexole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050637" MajorTopicYN="N">Receptors, Dopamine D3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013649" MajorTopicYN="N">Taste</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052160" MajorTopicYN="N">Benzothiazoles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D2/D3 receptor agonism</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">pramipexole</Keyword><Keyword MajorTopicYN="N">taste disorders</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>31</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35908177</ArticleId><ArticleId IdType="pmc">PMC9670739</ArticleId><ArticleId IdType="doi">10.1093/ijnp/pyac042</ArticleId><ArticleId IdType="pii">6652496</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akbar U, He Y, Dai Y, Hack N, Malaty I, McFarland NR, Hess C, Schmidt P, Wu S, Okun MS (2015) Weight loss and impact on quality of life in Parkinson&#x2019;s disease. PLoS One 10:e0124541. doi:10.1371/journal.pone.0124541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124541</ArticleId><ArticleId IdType="pmc">PMC4418600</ArticleId><ArticleId IdType="pubmed">25938478</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik JH (2013) Dopamine signaling in reward-related behaviors. Front Neural Circuits 7:152. doi:10.3389/fncir.2013.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2013.00152</ArticleId><ArticleId IdType="pmc">PMC3795306</ArticleId><ArticleId IdType="pubmed">24130517</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudjarane MA, Grandgeorge M, Marianowski R, Misery L, Lemonnier E (2017) Perception of odors and tastes in autism spectrum disorders: a systematic review of assessments. Autism Res 10:1045&#x2013;1057. doi:10.1002/aur.1760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aur.1760</ArticleId><ArticleId IdType="pubmed">28371114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini MP, Fasano A, Boschi F, Osculati F, Tinazzi M (2015) Taste in Parkinson&#x2019;s disease. J Neurol 262:806&#x2013;813. doi:10.1007/s00415-014-7518-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7518-1</ArticleId><ArticleId IdType="pubmed">25280862</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini MP, Tamburin S, Zanini A, Boschi F, Demartini B, Goeta D, Dallocchio C, Marotta A, Fiorio M, Tinazzi M (2020) Hedonicity in functional motor disorders: a chemosensory study assessing taste. J Neural Transm (Vienna) 127:1399&#x2013;1407. doi:10.1007/s00702-020-02244-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-020-02244-5</ArticleId><ArticleId IdType="pmc">PMC7497316</ArticleId><ArticleId IdType="pubmed">32856158</ArticleId></ArticleIdList></Reference><Reference><Citation>Churnin I, Qazi J, Fermin CR, Wilson JH, Payne SC, Mattos JL (2019) Association between olfactory and gustatory dysfunction and cognition in older adults. Am J Rhinol Allergy 33:170&#x2013;177. doi:10.1177/1945892418824451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892418824451</ArticleId><ArticleId IdType="pubmed">30632380</ArticleId></ArticleIdList></Reference><Reference><Citation>Contri-Degiovanni PV, Degiovanni GC, Ferriolli E, da Costa Lima NK, Moriguti JC (2020) Impact of the severity of dementia due to Alzheimer&#x2019;s disease on the gustatory sensitivity of older persons. Aging Clin Exp Res 32:2303&#x2013;2309. doi:10.1007/s40520-019-01442-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-019-01442-w</ArticleId><ArticleId IdType="pubmed">31894565</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL (2019) Treatments for smell and taste disorders: a critical review. Handb Clin Neurol 164:455&#x2013;479. doi:10.1016/B978-0-444-63855-7.00025-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00025-3</ArticleId><ArticleId IdType="pubmed">31604562</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL, Hawkes CH (2019) Chemosensory dysfunction in neurodegenerative diseases. Handb Clin Neurol 164:325&#x2013;360. doi:10.1016/B978-0-444-63855-7.00020-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00020-4</ArticleId><ArticleId IdType="pubmed">31604557</ArticleId></ArticleIdList></Reference><Reference><Citation>Haehner A, Masala C, Walter S, Reichmann H, Hummel T (2019) Incidence of Parkinson&#x2019;s disease in a large patient cohort with idiopathic smell and taste loss. J Neurol 266:339&#x2013;345. doi:10.1007/s00415-018-9135-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9135-x</ArticleId><ArticleId IdType="pubmed">30488238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Lang AE (2015) Parkinson&#x2019;s disease. Lancet 386:896&#x2013;912. doi:10.1016/S0140-6736(14)61393-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61393-3</ArticleId><ArticleId IdType="pubmed">25904081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltenboeck A, Halahakoon DC, Harmer CJ, Cowen P, Browning M (2022) Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers. Int J Neuropsychopharmacol 2022 May 23;pyac030. doi:10.1093/ijnp/pyac030 Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyac030</ArticleId><ArticleId IdType="pmc">PMC9515131</ArticleId><ArticleId IdType="pubmed">35605609</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazour F, Richa S, Desmidt T, Lemaire M, Atanasova B, El Hage W (2017) Olfactory and gustatory functions in bipolar disorders: a systematic review. Neurosci Biobehav Rev 80:69&#x2013;79. doi:10.1016/j.neubiorev.2017.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.05.009</ArticleId><ArticleId IdType="pubmed">28506924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kershaw JC, Mattes RD (2018) Nutrition and taste and smell dysfunction. World J Otorhinolaryngol Head Neck Surg 4:3&#x2013;10. doi:10.1016/j.wjorl.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wjorl.2018.02.006</ArticleId><ArticleId IdType="pmc">PMC6051307</ArticleId><ArticleId IdType="pubmed">30035256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Oh ES, Lee JH, Moon JS, Oh JE, Shin JW, Lee KJ, Baek IC, Jeong SH, Song HJ, Sohn EH, Lee AY (2012) Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson&#x2019;s disease (PD). Arch Gerontol Geriatr 55:70&#x2013;72. doi:10.1016/j.archger.2011.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2011.06.022</ArticleId><ArticleId IdType="pubmed">21763014</ArticleId></ArticleIdList></Reference><Reference><Citation>Leland EM, Xie DX, Kamath V, Seal SM, Lin SY, Rowan NR (2022) Psychophysical chemosensory dysfunction in eating disorders: a qualitative systematic review. Eat Weight Disord 27:429&#x2013;447. doi:10.1007/s40519-021-01189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-021-01189-2</ArticleId><ArticleId IdType="pubmed">33876410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, Wang L, Guo S, Guo X, Xia Y, Wan F, Huang J, Lin Z, Wang T (2018) Weight loss and malnutrition in patients with Parkinson&#x2019;s disease: current knowledge and future prospects. Front Aging Neurosci 10:1. doi:10.3389/fnagi.2018.00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00001</ArticleId><ArticleId IdType="pmc">PMC5780404</ArticleId><ArticleId IdType="pubmed">29403371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani E, Mariotto S, Gabbiani D, Dorelli G, Bozzetti S, Federico A, Zanzoni S, Girelli D, Crisafulli E, Ferrari S, Tamburin S (2021) Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? J Neurovirol 27:631&#x2013;637. doi:10.1007/s13365-021-01002-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-01002-x</ArticleId><ArticleId IdType="pmc">PMC8328351</ArticleId><ArticleId IdType="pubmed">34341960</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigam M, Ayadi I, Noiray C, Branquino-Bras AC, Herraez Sanchez E, Leu-Semenescu S, Vidailhet M, Dodet P, Arnulf I (2021) Sweet or bland dreams? Taste loss in isolated REM-sleep behavior disorder and Parkinson&#x2019;s disease. Mov Disord 36:2431&#x2013;2435. doi:10.1002/mds.28692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28692</ArticleId><ArticleId IdType="pubmed">34117799</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen LT, Mukerji SS, Mejia NI (2022) Post-acute neurological consequences of COVID-19: an unequal burden. Nat Med 28:20&#x2013;23. doi:10.1038/s41591-021-01647-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Pont-Sunyer C, et al. (2015) The onset of nonmotor symptoms in Parkinson&#x2019;s disease (the ONSET PD study). Mov Disord 30:229&#x2013;237. doi:10.1002/mds.26077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26077</ArticleId><ArticleId IdType="pubmed">25449044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai M, Kazui H, Shigenobu K, Komori K, Ikeda M, Nishikawa T (2017) Gustatory dysfunction as an early symptom of semantic dementia. Dement Geriatr Cogn Dis Extra 7:395&#x2013;405. doi:10.1159/000481854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481854</ArticleId><ArticleId IdType="pmc">PMC5806165</ArticleId><ArticleId IdType="pubmed">29430242</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K (2002) Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer&#x2019;s disease. Neurobiol Aging 23:397&#x2013;404. doi:10.1016/s0197-4580(01)00337-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(01)00337-2</ArticleId><ArticleId IdType="pubmed">11959402</ArticleId></ArticleIdList></Reference><Reference><Citation>Seppi K, Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C; the collaborators of the Parkinson&#x2019;s Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee (2019) Update on treatments for nonmotor symptoms of Parkinson&#x2019;s disease-an evidence-based medicine review. Mov Disord 34:180&#x2013;198. doi:10.1002/mds.27602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27602</ArticleId><ArticleId IdType="pmc">PMC6916382</ArticleId><ArticleId IdType="pubmed">30653247</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergi G, Bano G, Pizzato S, Veronese N, Manzato E (2017) Taste loss in the elderly: possible implications for dietary habits. Crit Rev Food Sci Nutr 57:3684&#x2013;3689. doi:10.1080/10408398.2016.1160208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1160208</ArticleId><ArticleId IdType="pubmed">27129026</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TD, Bhatnagar KP (2019) Anatomy of the olfactory system. Handb Clin Neurol 164:17&#x2013;28. doi:10.1016/B978-0-444-63855-7.00002-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00002-2</ArticleId><ArticleId IdType="pubmed">31604545</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani A, et al. (2021) Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain 144:1118&#x2013;1126. doi:10.1093/brain/awab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab005</ArticleId><ArticleId IdType="pubmed">33855335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Man REK, Gan ATL, Fenwick EK, Varadaraj V, Swenor BK, Gupta P, Wong TY, Trevisan C, Lorenzo-L&#xf3;pez L, Mill&#xe1;n-Calenti JC, Schwanke CHA, Liljas A, Al Snih S, Tokuda Y, Lamoureux EL (2020) Is sensory loss an understudied risk factor for frailty? A systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci 75:2461&#x2013;2470. Erratum in: J Gerontol A Biol Sci Med Sci 77:e109. doi.org/10.1093/gerona/glaa171</Citation><ArticleIdList><ArticleId IdType="pubmed">32735331</ArticleId></ArticleIdList></Reference><Reference><Citation>Tundo A, de Filippis R, De Crescenzo F (2019) Pramipexole in the treatment of unipolar and bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand 140:116&#x2013;125. doi:10.1111/acps.13055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.13055</ArticleId><ArticleId IdType="pubmed">31111467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincis R, Fontanini A (2019) Central taste anatomy and physiology. Handb Clin Neurol 164:187&#x2013;204. doi:10.1016/B978-0-444-63855-7.00012-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00012-5</ArticleId><ArticleId IdType="pmc">PMC6989094</ArticleId><ArticleId IdType="pubmed">31604547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>